Cognitive Decline is Not inevitable: Why the Healthcare System Needs a Radical Rethink on Alzheimer's

For too long, Alzheimer’s disease has been seen as an unavoidable consequence of ageing — a tragic, one-way descent into cognitive decline that robs individuals of their identity and autonomy. Yet, emerging research, alongside practical evidence from root-cause approaches such as the Bredesen Protocol, reveals a startling truth: cognitive decline is not inevitable. We have the tools to prevent — and in some cases reverse — early cognitive impairment. So why is the healthcare system lagging behind?

A System Stuck in Crisis Mode

Traditional medicine approaches Alzheimer’s as an irreversible, progressive disease, focusing on symptom management rather than prevention. Billions are poured into pharmaceutical research for ‘silver bullet’ drugs aimed at clearing amyloid plaques. Yet these treatments have, at best, shown modest benefits. The recent buzz around amyloid-reducing drugs like lecanemab and donanemab is a case in point: they may slow cognitive decline slightly but fail to address the underlying causes driving the disease.

The reality is that amyloid plaques are a symptom, not the root cause. They’re part of the brain’s inflammatory response — a protective mechanism that forms when the brain is under threat from chronic inflammation, toxins, insulin resistance, infections, or nutrient deficiencies. By focusing on plaques, we’re missing the point. If you don’t address what’s triggering the brain’s alarm system, you won’t solve the problem.

The Case for a Preventative, Root-Cause Approach

There’s a growing body of evidence supporting a functional, systems-based approach to cognitive health that addresses the key drivers of brain decline. The Bredesen Protocol, developed by Dr Dale Bredesen, is one such model. It’s based on the idea that cognitive decline results from a combination of factors — from insulin resistance and chronic inflammation to toxins, nutrient deficiencies, and disrupted sleep.

Functional medicine practitioners working with this protocol don’t wait until a patient’s symptoms are severe. They assess early markers of cognitive risk, identify the root causes for each individual, and design personalised strategies to optimise brain health.

The results? Case studies show that early-stage Alzheimer’s patients have stabilised or even improved their cognition when the underlying drivers of inflammation and neurodegeneration are addressed. Yet, these approaches remain outside the remit of most conventional healthcare systems.

Why the NHS and Conventional Healthcare Systems Need a Rethink

Here in the UK, Alzheimer’s and other dementias are a leading cause of death. The cost to the NHS is staggering, and the human toll on families is immeasurable. But the current system is reactive, not preventative.

Patients are diagnosed once cognitive decline is already advanced. They’re often told there’s little to be done, other than to manage symptoms and plan for long-term care. It’s a devastating message that leaves patients feeling powerless. But it doesn’t have to be this way.

If we shift the focus towards early intervention and prevention, we could change the trajectory of cognitive health:

• Routine cognitive screenings could become part of annual health checks from middle age onwards.
• Blood tests assessing insulin resistance, inflammatory markers, toxins, and key nutrients like vitamin D, B12, and magnesium could identify risk factors long before symptoms appear.
• Personalised lifestyle interventions addressing diet, sleep, stress, and exercise could reduce the risk of neurodegeneration.
• Education campaigns could empower people to take control of their cognitive health decades before problems arise.

The tools exist. The evidence exists. What’s missing is a healthcare system willing to embrace this paradigm shift.

The Role of Entrepreneurs, Innovators, and Functional Medicine Practitioners

The good news is that the change is already happening — though it’s coming from outside traditional healthcare structures. Functional medicine practitioners, health tech innovators, and wellness entrepreneurs are leading the way in cognitive health. They’re providing people with the knowledge and tools to reduce their risk of dementia, often decades before symptoms appear.

However, this shift needs to scale.

We need public health bodies and policy makers to integrate root-cause, preventative approaches into national health strategies. We need GPs and primary care physicians to move beyond symptom-based care and embrace the power of functional, personalised medicine. We need business leaders and innovators to push for new models of care that don’t rely on a pharmaceutical fix.

A Call to Action: It’s Time to Change the Narrative

The narrative around cognitive decline must change from one of hopeless inevitability to one of hope and empowerment. The science is clear: the brain is not destined to fail with age. Alzheimer’s is not an unavoidable part of ageing — it’s a disease with identifiable, modifiable risk factors.

Here’s what needs to happen:

1. Integrate cognitive screening into routine health checks.
2. Shift funding towards root-cause research, not just pharmaceutical interventions.
3. Educate the public on lifestyle factors that protect brain health — from sleep and diet to mental stimulation and stress management.
4. Incentivise healthcare providers to embrace preventative, personalised approaches.

Let’s Rewrite the Future of Brain Health

Cognitive decline is a slow burn, often beginning decades before symptoms arise. This gives us a critical window of opportunity to intervene — but only if we recognise the signs early and address the root causes.

It’s time for the healthcare system to embrace a radical rethink on Alzheimer’s. Prevention is possible. Improvement is possible. We’re at the cusp of a new era in brain health, and it’s up to all of us — practitioners, policymakers, innovators, and individuals — to ensure we seize it.